Interview with Timo Müller About New Therapies for Obesity and Diabetes

Modern drugs for obesity and type 2 diabetes are based on a simple insight: metabolic pathways are not controlled by a single signal, but by many acting together. Prof. Timo D. Müller is Director of the Institute for Diabetes and Obesity (IDO) at Helmholtz Munich and Professor at the Ludwig Maximilians University of Munich (LMU). Together with his team, he investigates how these biological…